My Bibliography

select

Kong X, Wang B, Wu X, Cho H, Fu W, Li Q, Zhang R, Nasri U, Zheng M, Wu A, Qin H, Li JH, Pillai R, O'Sullivan TE, Nakamura R, Martin PJ, Chen Y, Zeng D. Stem-like memory-T maintenance and differentiation into tissue-resident T cells sustain chronic graft-versus-host disease in mice. Nat Commun. 2026 Feb 24;17(1). doi: 10.1038/s41467-026-69975-z. PubMed PMID: 41735346; PubMed Central PMCID: PMC13043700.

select

Song Q, Zheng M, Li Q, Wu X, Lin B, Kang TH, Qin H, Kujawski M, Pillai RK, Lin JL, Nakamura R, Shively J, Martin PJ, Zeng D. Intestinal epithelial Ceacam1 deficiency prevents steroid-refractory acute gut graft-versus-host disease. JCI Insight. 2025 Sep 9;10(17). doi: 10.1172/jci.insight.186984. eCollection 2025 Sep 9. PubMed PMID: 40923321; PubMed Central PMCID: PMC12487693.

select

Li Q, Wang X, Song Q, Yang S, Wu X, Yang D, Marié IJ, Qin H, Zheng M, Nasri U, Kong X, Wang B, Lizhar E, Cassady K, Tompkins J, Levy D, Martin PJ, Zhang X, Zeng D. Donor T cell STAT3 deficiency enables tissue PD-L1-dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity. J Clin Invest. 2023 Aug 1;133(15). doi: 10.1172/JCI165723. PubMed PMID: 37526084; PubMed Central PMCID: PMC10378157.

select

Zhang Y, Song Q, Cassady K, Lee M, Tang H, Zheng M, Wang B, Schones DE, Fu YX, Riggs AD, Martin PJ, Feng R, Zeng D. Blockade of trans PD-L1 interaction with CD80 augments antitumor immunity. Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2205085120. doi: 10.1073/pnas.2205085120. Epub 2023 Apr 10. PubMed PMID: 37036990; PubMed Central PMCID: PMC10120074.

select

Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. Blood Adv. 2022 Aug 23;6(16):4735. doi: 10.1182/bloodadvances.2022008513. PubMed PMID: 35972768; PubMed Central PMCID: PMC9631660.

select

Martin PJ, Levine DM, Storer BE, Sather CL, Spellman SR, Hansen JA. Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation. Blood Adv. 2022 Apr 26;6(8):2608-2617. doi: 10.1182/bloodadvances.2021005620. PubMed PMID: 34996099; PubMed Central PMCID: PMC9043943.

select

Mukherjee A, Gooley T, Mielcarek M, Sandmaier BM, Doney K, Oshima MU, Holmberg L, Baker KS, Salit RB, Krakow EF, Shannon-Dorcy K, Davis C, Lee SJ. Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipients. Bone Marrow Transplant. 2022 Mar;57(3):440-444. doi: 10.1038/s41409-021-01557-7. Epub 2022 Jan 31. PubMed PMID: 35095100; PubMed Central PMCID: PMC9464029.

select

Martin PJ, Levine DM, Storer BE, Zheng X, Jain D, Heavner B, Norris BM, Geraghty DE, Spellman SR, Sather CL, Wu F, Hansen JA. A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation. Front Immunol. 2021;12:782152. doi: 10.3389/fimmu.2021.782152. eCollection 2021. PubMed PMID: 34868058; PubMed Central PMCID: PMC8636906.

select

Martin PJ, Storer BE, Levine DM, Hansen JA. Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease. Blood Adv. 2021 Nov 9;5(21):4456-4464. doi: 10.1182/bloodadvances.2021004959. PubMed PMID: 34535014; PubMed Central PMCID: PMC8579259.

select

Casto AM, Seo S, Levine DM, Storer BE, Dong X, Hansen JA, Boeckh M, Martin PJ. Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation. Blood. 2021 Oct 28;138(17):1628-1636. doi: 10.1182/blood.2021012153. PubMed PMID: 34269803; PubMed Central PMCID: PMC8554648.

select

Cooper JP, Storer BE, Granot N, Gyurkocza B, Sorror ML, Chauncey TR, Shizuru J, Franke GN, Maris MB, Boyer M, Bruno B, Sahebi F, Langston AA, Hari P, Agura ED, Lykke Petersen S, Maziarz RT, Bethge W, Asch J, Gutman JA, Olesen G, Yeager AM, Hübel K, Hogan WJ, Maloney DG, Mielcarek M, Martin PJ, Flowers MED, Georges GE, Woolfrey AE, Deeg JH, Scott BL, McDonald GB, Storb R, Sandmaier BM. Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades. Haematologica. 2021 Jun 1;106(6):1599-1607. doi: 10.3324/haematol.2020.248187. PubMed PMID: 32499241; PubMed Central PMCID: PMC8168504.

select

Kong X, Zeng D, Wu X, Wang B, Yang S, Song Q, Zhu Y, Salas M, Qin H, Nasri U, Haas KM, Riggs AD, Nakamura R, Martin PJ, Huang A, Zeng D. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity. J Clin Invest. 2021 Jan 4;131(1). doi: 10.1172/JCI135468. PubMed PMID: 32931481; PubMed Central PMCID: PMC7773409.

select

Mohty M, Holler E, Jagasia M, Jenq R, Malard F, Martin P, Socié G, Zeiser R. Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness. Blood. 2020 Oct 22;136(17):1903-1906. doi: 10.1182/blood.2020007336. Review. PubMed PMID: 32756949.

select

Martin PJ, Levine DM, Storer BE, Nelson SC, Dong X, Hansen JA. Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation. Blood Adv. 2020 Jul 28;4(14):3224-3233. doi: 10.1182/bloodadvances.2020001927. PubMed PMID: 32687560; PubMed Central PMCID: PMC7391140.

select

Inamoto Y, Martin PJ, Lee SJ, Momin AA, Tabellini L, Onstad LE, Pidala J, Flowers MED, Lawler RL, Katayama H, Hanash S, Hansen JA. Dickkopf-related protein 3 is a novel biomarker for chronic GVHD after allogeneic hematopoietic cell transplantation. Blood Adv. 2020 Jun 9;4(11):2409-2417. doi: 10.1182/bloodadvances.2020001485. PubMed PMID: 32492155; PubMed Central PMCID: PMC7284089.

select

Martin PJ. How I treat steroid-refractory acute graft-versus-host disease. Blood. 2020 May 7;135(19):1630-1638. doi: 10.1182/blood.2019000960. PubMed PMID: 32202630.

select

McDonald GB, Sandmaier BM, Mielcarek M, Sorror M, Pergam SA, Cheng GS, Hingorani S, Boeckh M, Flowers MD, Lee SJ, Appelbaum FR, Storb R, Martin PJ, Deeg HJ, Schoch G, Gooley TA. Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts. Ann Intern Med. 2020 Feb 18;172(4):229-239. doi: 10.7326/M19-2936. Epub 2020 Jan 21. PubMed PMID: 31958813; PubMed Central PMCID: PMC7847247.

select

Inamoto Y, Lee SJ, Onstad LE, Flowers MED, Hamilton BK, Jagasia MH, Martin PJ, Pavletic SZ, Pidala JA, Pusic I, Vogelsang GB, Wolff D, Carpenter PA. Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia. Blood Adv. 2020 Jan 14;4(1):40-46. doi: 10.1182/bloodadvances.2019000918. PubMed PMID: 31899796; PubMed Central PMCID: PMC6960471.

select

Hamilton BK, Storer BE, Wood WA, Pidala JA, Cutler CS, Martin PJ, Chen G, Flowers ME, Lee SJ. Disability Related to Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020 Apr;26(4):772-777. doi: 10.1016/j.bbmt.2019.10.019. Epub 2019 Oct 24. PubMed PMID: 31669175; PubMed Central PMCID: PMC7180104.

select

Inamoto Y, White J, Ito R, Martin PJ, Fatobene G, Ito A, Tanaka T, Kurosawa S, Kim SW, Bar M, Sorror ML, Sandmaier BM, Lee SJ, Fukuda T, Flowers MED. Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients. Blood Adv. 2019 Sep 24;3(18):2764-2777. doi: 10.1182/bloodadvances.2019000386. PubMed PMID: 31551243; PubMed Central PMCID: PMC6759734.

select

Kebriaei P, Hayes J, Daly A, Uberti J, Marks DI, Soiffer R, Waller EK, Burke E, Skerrett D, Shpall E, Martin PJ. A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2020 May;26(5):835-844. doi: 10.1016/j.bbmt.2019.08.029. Epub 2019 Sep 7. PubMed PMID: 31505228; PubMed Central PMCID: PMC7060124.

select

Pidala JA, Hamilton BK, Martin PJ, Onstad L, Storer BE, Palmer J, Alousi A, Cutler C, Jagasia MH, Chen GL, Arora M, Flowers ME, Lee SJ. The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index. Biol Blood Marrow Transplant. 2019 Dec;25(12):2468-2473. doi: 10.1016/j.bbmt.2019.07.040. Epub 2019 Aug 5. PubMed PMID: 31394265; PubMed Central PMCID: PMC6900444.

select

Sandmaier BM, Kornblit B, Storer BE, Olesen G, Maris MB, Langston AA, Gutman JA, Petersen SL, Chauncey TR, Bethge WA, Pulsipher MA, Woolfrey AE, Mielcarek M, Martin PJ, Appelbaum FR, Flowers MED, Maloney DG, Storb R. Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial. Lancet Haematol. 2019 Aug;6(8):e409-e418. doi: 10.1016/S2352-3026(19)30088-2. Epub 2019 Jun 24. PubMed PMID: 31248843; PubMed Central PMCID: PMC6686903.

select

Martin PJ, Storer BE, Palmer J, Jagasia MH, Chen GL, Broady R, Arora M, Pidala JA, Hamilton BK, Lee SJ. Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2019 Sep;25(9):1869-1874. doi: 10.1016/j.bbmt.2019.05.008. Epub 2019 May 11. PubMed PMID: 31085305; PubMed Central PMCID: PMC6755054.

select

McCune JS, Wang T, Bo-Subait K, Aljurf M, Beitinjaneh A, Bubalo J, Cahn JY, Cerny J, Chhabra S, Cumpston A, Dupuis LL, Lazarus HM, Marks DI, Maziarz RT, Norkin M, Prestidge T, Mineishi S, Krem MM, Pasquini M, Martin PJ. Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning. Biol Blood Marrow Transplant. 2019 Jul;25(7):1424-1431. doi: 10.1016/j.bbmt.2019.03.001. Epub 2019 Mar 11. PubMed PMID: 30871976; PubMed Central PMCID: PMC6615968.

select

Cassady K, Martin PJ, Zeng D. Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80. Front Immunol. 2018;9:3061. doi: 10.3389/fimmu.2018.03061. eCollection 2018. Review. PubMed PMID: 30622541; PubMed Central PMCID: PMC6308317.

select

Fatobene G, Storer BE, Salit RB, Lee SJ, Martin PJ, Cheng GS, Carpenter PA, Balgansuren G, Petersdorf EW, Delaney C, Sandmaier BM, Milano F, Flowers ME. Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation. Haematologica. 2019 Apr;104(4):835-843. doi: 10.3324/haematol.2018.202754. Epub 2018 Nov 15. PubMed PMID: 30442722; PubMed Central PMCID: PMC6442956.

select

Rozmus J, Kariminia A, Abdossamadi S, Storer BE, Martin PJ, Lee SJ, Wolff D, Arora M, Cutler C, Schultz KR. Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis. Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14. PubMed PMID: 30447393; PubMed Central PMCID: PMC6445755.

select

Lee SJ, Onstad L, Chow EJ, Shaw BE, Jim HSL, Syrjala KL, Baker KS, Buckley S, Flowers ME. Patient-reported outcomes and health status associated with chronic graft-versus-host disease. Haematologica. 2018 Sep;103(9):1535-1541. doi: 10.3324/haematol.2018.192930. Epub 2018 Jun 1. PubMed PMID: 29858386; PubMed Central PMCID: PMC6119141.

select

Syrjala KL, Crouch ML, Leisenring WM, Flowers MED, Artherholt SB, Fiscalini AS, Romano E, Romano JM, Martin PJ, Yi JC. Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant. 2018 Aug;24(8):1692-1698. doi: 10.1016/j.bbmt.2018.05.004. Epub 2018 May 9. PubMed PMID: 29753161; PubMed Central PMCID: PMC6370551.

select

Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM. An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv. 2018 Aug;12(4):560-570. doi: 10.1007/s11764-018-0693-9. Epub 2018 May 5. PubMed PMID: 29730827; PubMed Central PMCID: PMC6054554.

select

Martin PJ. Pathogenic neutrophils in acute GVHD. Blood. 2018 Apr 19;131(16):1774-1775. doi: 10.1182/blood-2018-03-836353. PubMed PMID: 29674354.

select

Martin PJ. Bortezomib for prevention of acute graft-versus-host disease: a conclusion reached. Haematologica. 2018 Mar;103(3):377-379. doi: 10.3324/haematol.2018.188052. PubMed PMID: 29491127; PubMed Central PMCID: PMC5830384.

select

Leger KJ, Baker KS, Cushing-Haugen KL, Flowers MED, Leisenring WM, Martin PJ, Mendoza JA, Reding KW, Syrjala KL, Lee SJ, Chow EJ. Lifestyle factors and subsequent ischemic heart disease risk after hematopoietic cell transplantation. Cancer. 2018 Apr 1;124(7):1507-1515. doi: 10.1002/cncr.31227. Epub 2018 Jan 9. PubMed PMID: 29315507; PubMed Central PMCID: PMC5867247.

select

Lee SJ, Nguyen TD, Onstad L, Bar M, Krakow EF, Salit RB, Carpenter PA, Rodrigues M, Hall AM, Storer BE, Martin PJ, Flowers ME. Success of Immunosuppressive Treatments in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018 Mar;24(3):555-562. doi: 10.1016/j.bbmt.2017.10.042. Epub 2017 Nov 10. PubMed PMID: 29133250; PubMed Central PMCID: PMC5826880.

select

Green DJ, Maloney DG, Storer BE, Sandmaier BM, Holmberg LA, Becker PS, Fang M, Martin PJ, Georges GE, Bouvier ME, Storb R, Mielcarek M. Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma. Blood Adv. 2017 Nov 14;1(24):2247-2256. doi: 10.1182/bloodadvances.2017010686. eCollection 2017 Nov 14. PubMed PMID: 29296873; PubMed Central PMCID: PMC5737131.

select

Deng R, Hurtz C, Song Q, Yue C, Xiao G, Yu H, Wu X, Muschen M, Forman S, Martin PJ, Zeng D. Extrafollicular CD4(+) T-B interactions are sufficient for inducing autoimmune-like chronic graft-versus-host disease. Nat Commun. 2017 Oct 17;8(1):978. doi: 10.1038/s41467-017-00880-2. PubMed PMID: 29042531; PubMed Central PMCID: PMC5645449.

select

Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20;35(36):4003-4011. doi: 10.1200/JCO.2017.75.8177. Epub 2017 Oct 17. PubMed PMID: 29040031; PubMed Central PMCID: PMC8462523.

select

Hamilton BK, Rybicki L, Arai S, Arora M, Cutler CS, Flowers MED, Jagasia M, Martin PJ, Palmer J, Pidala J, Majhail NS, Lee SJ, Khera N. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes. Biol Blood Marrow Transplant. 2018 Feb;24(2):393-399. doi: 10.1016/j.bbmt.2017.10.009. Epub 2017 Oct 12. PubMed PMID: 29032275; PubMed Central PMCID: PMC5767523.

select

Steinbach G, Hockenbery DM, Huls G, Furlong T, Myerson D, Loeb KR, Fann JR, Castilla-Llorente C, McDonald GB, Martin PJ. Pilot study of lithium to restore intestinal barrier function in severe graft-versus-host disease. PLoS One. 2017;12(8):e0183284. doi: 10.1371/journal.pone.0183284. eCollection 2017. PubMed PMID: 28817727; PubMed Central PMCID: PMC5560707.

select

Carpenter PA, Johnston L, Fernandez HF, Radich JP, Mauro MJ, Flowers MED, Martin PJ, Gooley TA. Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia. Blood. 2017 Aug 31;130(9):1170-1172. doi: 10.1182/blood-2017-03-771121. Epub 2017 Jul 11. PubMed PMID: 28698203.

select

Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, Palmer J, Arora M, Jagasia M, Arai S, Cutler CS, Lee SJ. An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease. Blood. 2017 Jul 20;130(3):360-367. doi: 10.1182/blood-2017-03-775767. Epub 2017 May 11. PubMed PMID: 28495794; PubMed Central PMCID: PMC5520473.

select

McDonald GB, Tabellini L, Storer BE, Martin PJ, Lawler RL, Rosinski SL, Schoch HG, Hansen JA. Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease. Biol Blood Marrow Transplant. 2017 Aug;23(8):1257-1263. doi: 10.1016/j.bbmt.2017.04.029. Epub 2017 May 3. PubMed PMID: 28478120; PubMed Central PMCID: PMC5555298.

select

Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, Flowers MED, Lee SJ, Carpenter PA, Storer BE, Hanash S, Hansen JA. Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Aug;23(8):1250-1256. doi: 10.1016/j.bbmt.2017.04.019. Epub 2017 Apr 25. PubMed PMID: 28455006; PubMed Central PMCID: PMC5511087.

select

Ni X, Song Q, Cassady K, Deng R, Jin H, Zhang M, Dong H, Forman S, Martin PJ, Chen YZ, Wang J, Zeng D. PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells. J Clin Invest. 2017 May 1;127(5):1960-1977. doi: 10.1172/JCI91138. Epub 2017 Apr 17. PubMed PMID: 28414296; PubMed Central PMCID: PMC5409099.

select

Fisher CE, Hohl TM, Fan W, Storer BE, Levine DM, Zhao LP, Martin PJ, Warren EH, Boeckh M, Hansen JA. Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation. Blood. 2017 May 11;129(19):2693-2701. doi: 10.1182/blood-2016-10-743294. Epub 2017 Mar 7. PubMed PMID: 28270451; PubMed Central PMCID: PMC5428460.

select

Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung YJ, Lee D, Kunkel L, Negrin RS, Bui JD. Increased Foxp3(+)Helios(+) Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells. Biol Blood Marrow Transplant. 2017 Apr;23(4):625-634. doi: 10.1016/j.bbmt.2017.01.069. Epub 2017 Jan 16. PubMed PMID: 28104514; PubMed Central PMCID: PMC5437739.

select

Watkins BK, Horan J, Storer B, Martin PJ, Carpenter PA, Flowers ME. Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant. Bone Marrow Transplant. 2017 Apr;52(4):625-626. doi: 10.1038/bmt.2016.328. Epub 2016 Dec 19. PubMed PMID: 27991888.

select

Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, Socie G, Anasetti C. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017 Mar;23(3):405-411. doi: 10.1016/j.bbmt.2016.12.624. Epub 2016 Dec 19. PubMed PMID: 28007665; PubMed Central PMCID: PMC6716167.

select

Martin PJ, Levine DM, Storer BE, Warren EH, Zheng X, Nelson SC, Smith AG, Mortensen BK, Hansen JA. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease. Blood. 2017 Feb 9;129(6):791-798. doi: 10.1182/blood-2016-09-737700. Epub 2016 Nov 21. PubMed PMID: 27872059; PubMed Central PMCID: PMC5301826.